Patent · US Active

Methods for assessing risk of developing a viral disease using a genetic test

US10941448B1 · kind B1 · utility

7Cited by

69References

36Claims

0Family size

Assignees

UNIVERSITE PARIS-SACLAY
ASSISTANCE PUBLIQUE—HÔPITAUX DE PARIS (APHP) · FR
Institut National de la Sante et de la Recherche Medicale (INSERM) · FR
PML Screening, LLC · US

Inventors

Eli Hatchwell · Smithtown, US
Peggy S. Eis · Fitchburg, US
Edward B. Smith, III · Seattle, US
Yassine Taoufik · Paris, FR

Key dates

Filing date	Jan 11, 2019
Grant date	Mar 9, 2021
Priority date	—
Expiry date	Jan 11, 2039

Classification

Technology area (CPC G)Physics
CPC primaryG01N2800/52
WIPO fieldPharmaceuticals
WIPO sectorChemistry

Abstract

This document provides methods and materials related to treating a disease. For example, this document provides methods for treating a subject's disease based on identifying the risk of progressive multifocal leukoencephalopathy PML using a genetic test.

Source: USPTO / EPO open patent data. Objective bibliographic and citation counts.